<DOC>
	<DOCNO>NCT01350583</DOCNO>
	<brief_summary>The purpose study : - Determine well people tolerate sodium bicarbonate take mouth high dose usually give heartburn . - Determine sodium bicarbonate reduce cancer-related pain . Right , investigator know sure high dos well tolerate reduce pain associated cancer . The investigator study see sodium bicarbonate well tolerate reduce requirement pain medication .</brief_summary>
	<brief_title>Bicarbonate Tumor Related Pain</brief_title>
	<detailed_description>The study single institution , non-randomized , single arm pilot study evaluate efficacy adjuvant therapy sodium bicarbonate tumor relate pain . Patients receive sodium bicarbonate ( 0.15 g/kg/day 1 week tolerate 0.3 g/kg/day one week dose tolerate 0.6 g/kg/day ) 4 week . The sodium bicarbonate provide patient powder consume mixed 250 cc ( 1 cup ) water . In consultation PI , patient permit mix sodium bicarbonate commercially available drink instead water provide liquid acid/base balance ( pH ) 7.4 great . Patients good tolerance study therapy least 30 % improvement pain intensity ( VAS ) compare baseline 3 week therapy wish continue study therapy allow continue sodium bicarbonate therapy direction treat physician . Patients without least 30 % improvement pain intensity 3 week discontinue study therapy .</detailed_description>
	<criteria>Patients must metastatic unresectable solid malignancy hematologic malignancy ( multiple myeloma lymphoma ) must moderate severe tumor relate pain ( VAS &gt; 4 ) stable opioid regimen ( least 3 day opiate regimen ) . No planned palliative surgery , palliative radiotherapy least 2 week . However prior radiotherapy , surgery allow limited number procedure course . Concomitant chemotherapy allow . In addition , anticipate chemotherapy may result rapid pain relief ( le 2 week ) , patient enrol complete first cycle chemotherapy provide pain level great 4 VAS . No evidence neurologic psychiatric compromise opinion investigator interfere completion study assessment Life expectancy great 3 month Age great 18 year able understand sign inform consent document Patients must Eastern cooperative oncology group ( ECOG ) performance status less 4 . Patients neuropathy and/or neuropathic pain pain syndrome eligible . Patients chronic non malignant pain eligible . Patients renal insufficiency ( creatinine &gt; 2.5 mg/dL ) exclude Patients history congestive heart failure pulmonary artery hypertension exclude Any patient opinion investigator dehydrate time initial evaluation exclude . Patients uncontrolled hypertension ( systolic pressure &gt; 140 , diastolic pressure &gt; 90 ) despite maximal antihypertensive therapy . Patients unable ingest oral sodium bicarbonate ( patient dysphagia severe nausea ) Patients ECOG performance status 4 Patients acute leukemia , myelodysplastic syndrome , chronic myeloid leukemia eligible . Pregnant lactate patient eligible . Patients estimate survival less 3 month Patients know allergy sodium bicarbonate patient preexist renal acid base disorder sodium bicarbonate contraindicate ( metabolic alkalosis , severe congestive heart failure , hypernatremia , hypocalcemia [ see ] ) . Patients severe ongoing infection place patient increase risk therapy opinion investigator . Patients receive receive , participation study , oral chemotherapeutic agent whose bioavailability could alter ingestion sodium bicarbonate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>tumor relate pain</keyword>
</DOC>